FPS
RDY icon

Fieldpoint Private Securities’s Dr. Reddy's Laboratories RDY Stock Holding History

Fieldpoint Private Securities’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$3K Hold
250
– – ﹤0.01% 1090
2022
Q1 		$3K Hold
250
– – ﹤0.01% 1430
2021
Q4 		$3K Hold
250
– – ﹤0.01% 1415
2021
Q3 		$3K Sell
250
-100
-29% -$1.33K ﹤0.01% 1403
2021
Q2 		$4K Sell
350
-100
-22% -$1.4K ﹤0.01% 1282
2021
Q1 		$6K Buy
450
+200
+80% +$2.57K ﹤0.01% 1151
2020
Q4 		$4K Buy
+250
New +$3.37K ﹤0.01% 1193

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Fieldpoint Private Securities's RDY Position: Q2 2022 in Review

Fieldpoint Private Securities held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2022 at 250 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1090.

Fieldpoint Private Securities first reported a position in RDY in Q4 2020 and has held it in 7 quarters since. The position peaked at $6K in Q1 2021. 148 funds tracked by Wall St. Rank hold RDY as of Q2 2022.

  • Fieldpoint Private Securities held 250 shares of Dr. Reddy's Laboratories worth $3K as of Q2 2022.
  • Fieldpoint Private Securities left its Dr. Reddy's Laboratories share count unchanged in Q2 2022.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1090 holding.
  • Fieldpoint Private Securities first reported a position in Dr. Reddy's Laboratories in Q4 2020 and has held it in 7 quarters since.
  • Fieldpoint Private Securities's Dr. Reddy's Laboratories position peaked at $6K in Q1 2021.
  • 148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.